These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3992737)

  • 1. Adverse effects during endocrine therapy for prostatic carcinoma with a high dose of estrogen.
    Shinkawa T; Ohfuji T; Osada Y; Ishisawa N
    Urol Int; 1985; 40(2):103-6. PubMed ID: 3992737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Liver damage in hormone therapy of prostate cancer].
    Zade W; Schott H
    Z Urol Nephrol; 1987 Mar; 80(3):177-9. PubMed ID: 3604474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II study of high-dose estrogens (diethylstilbestrol diphosphate) in prostate cancer.
    Citrin DL; Kies MS; Wallemark CB; Khandekar J; Kaplan E; Camacho F; Lind R
    Cancer; 1985 Aug; 56(3):457-60. PubMed ID: 4005808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of castration versus intravenous estrogen therapy in producing rapid endocrine control of metastatic cancer of the prostate.
    Maatman TJ; Gupta MK; Montie JE
    J Urol; 1985 Apr; 133(4):620-1. PubMed ID: 3981712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenocortical insufficiency associated with long-term high-dose fosfestrol therapy for prostatic carcinoma.
    Iida H; Miyamoto I; Noda Y; Sawaki M; Nagai Y
    Intern Med; 1999 Oct; 38(10):804-7. PubMed ID: 10526944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diethylstilbestrol-diphosphate-induced disseminated intravascular coagulation in prostatic carcinoma.
    Cornfield DB; Rossman RE
    South Med J; 1982 Feb; 75(2):248-9. PubMed ID: 7058376
    [No Abstract]   [Full Text] [Related]  

  • 7. Response of serum cholesterol and triglycerides to hormone treatment and the relation of pretreatment values to mortality in patients with prostatic cancer.
    Seal US; Doe RP; Byar DP; Corle DK
    Cancer; 1976 Sep; 38(3):1095-107. PubMed ID: 182347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intermittent diethylstilbestrol diphosphate administration on the R3327 rat prostatic carcinoma.
    Russo P; Liguori G; Heston WD; Huryk R; Yang CR; Fair WR; Whitmore WF; Herr HW
    Cancer Res; 1987 Nov; 47(22):5967-70. PubMed ID: 3664500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Side effects of estrogen administration to prostatic cancer patients: clinical and statistical survey of 109 prostatic cancer cases of Kyoto University Hospital].
    Oishi K; Arai Y; Takeuchi H; Yoshida O
    Hinyokika Kiyo; 1993 Jan; 39(1):23-8. PubMed ID: 8460581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Estrogen therapy of prostatic cancer. 76 cases of previously undiagnosed prostatic cancer treated with F6066 (bis-(p-acetoxyphenyl)cyclohexylidenemethane) and diethylstilbestrol--a double-blind study].
    Carstensen HE; Olsen CE; Sele V; Brorson I; Jensen E; Nissen NI; Fabricius J
    Nord Med; 1969 Jan; 81(4):111-4. PubMed ID: 4888811
    [No Abstract]   [Full Text] [Related]  

  • 11. The serum levels of testosterone and prolactin in patients with prostatic carcinoma treated with various doses of Fostrolin and bromocriptin.
    Jeromin L
    Int Urol Nephrol; 1982; 14(1):51-6. PubMed ID: 6889585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasma levels of fosfestrol and its monophosphate, of diethylstilbestrol and its monoglucuronide following intravenous administration in patients with metastatic prostatic carcinoma].
    Oelschläger H; Rothley D; Dunzendorfer U
    Arzneimittelforschung; 1984; 34(10):1333-6. PubMed ID: 6542793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Honvan-high-dose therapy of prostatic carcinoma with metastases: early complications and value of prophylaxis against thrombosis].
    Heinz A; Meyer WW; Hallwachs O
    Urologe A; 1982 Jul; 21(4):232-4. PubMed ID: 6890263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The usefulness of hormonal therapy in the treatment of prostatic cancer--clinical analysis of 160 cases over 12 years in the single institute].
    Hayakawa K; Kimura S; Ikeuchi K
    Nihon Hinyokika Gakkai Zasshi; 1994 Aug; 85(8):1256-62. PubMed ID: 7933760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of long-term estrogen treatment on liver function in patients with prostatic carcinoma.
    Ishibe T
    J Urol; 1975 Jun; 113(6):829-33. PubMed ID: 1152157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of giant prostate cancer].
    Fujimoto Y; Yamaha M; Maeda S; Takeuchi T; Ito Y; Kuriyama M; Ban Y; Nishiura T
    Hinyokika Kiyo; 1984 Jul; 30(7):925-30. PubMed ID: 6542303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose diethylstilbestrol diphosphate therapy of prostatic cancer after failure of standard doses of estrogens.
    Band PR; Banerjee TK; Patwardhan VC; Eid TC
    Can Med Assoc J; 1973 Oct; 109(8):697-9. PubMed ID: 4746128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical studies on endocrine therapy of prostatic carcinoma (2): Prognosis of patients with prostatic carcinoma given endocrine therapy, and analyses of causes of death and side effects of endocrine therapy].
    Kumamoto Y; Tsukamoto T; Umehara T; Shimazaki J; Fuse H; Oshima H; Takeuchi H; Yoshida O; Okada K; Saito Y
    Hinyokika Kiyo; 1990 Mar; 36(3):285-93. PubMed ID: 2191570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hormonal treatment of carcinoma of the prostate].
    Obata K; Kobayashi H; Murase T; Ohisi M
    Hinyokika Kiyo; 1991 Aug; 37(8):809-16. PubMed ID: 1720272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous endocrine management and chemotherapy as initial treatment in M1 prostatic carcinoma.
    Richards B
    Prog Clin Biol Res; 1988; 269():177-86. PubMed ID: 2839846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.